Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Combination therapy has been one of the cornerstones for combating cancers. Even though the survival rate of cancer patients after receiving combination therapy is improved dramatically, there are still many unsolved issues to prevent us from claiming combination therapy is a cure for cancers. Those issues include it does not apply to all types of cancers; there are increased risks of side effects, and it requires long developmental time and huge costs. One approach to resolve these issues is applying multiple-compound multiple-target paradigm directly during discovery processes, which exactly is the backbone of the partner organization’s proprietary drug discovery technology. Yet the technology lacks an appropriate and efficient way to predict the effects of combinations. Therefore, the proposal aims not only to improve this technology but also resolve issues in combination therapy.
Jack Tuszynski
SinoVeda Canada Inc
Physics
Agriculture; Manufacturing; Professional, scientific and technical services
University of Alberta
Elevate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.